hydroxychloroquine
Selected indexed studies
- Hydroxychloroquine: A double‑edged sword (Review). (Mol Med Rep, 2025) [PMID:39981928]
- Hydroxychloroquine and COVID-19: a Rheumatologist's Take on the Lessons Learned. (Curr Allergy Asthma Rep, 2021) [PMID:33475900]
- Hydroxychloroquine as an Adjunct Therapy for Diabetes in Pregnancy. (Int J Mol Sci, 2024) [PMID:39273629]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Hydroxychloroquine: A double‑edged sword (Review). (2025) pubmed
- Hydroxychloroquine and COVID-19: a Rheumatologist's Take on the Lessons Learned. (2021) pubmed
- Hydroxychloroquine as an Adjunct Therapy for Diabetes in Pregnancy. (2024) pubmed
- Will Hydroxychloroquine Still Be a Game-Changer for COVID-19 by Combining Azithromycin? (2020) pubmed
- Hydroxychloroquine and COVID-19 - A narrative review. (2020) pubmed
- Hydroxychloroquine as prophylaxis or treatment for COVID-19: What does the evidence say? (2020) pubmed
- Hydroxychloroquine Ocular Toxicity: A Comprehensive Review. (2026) pubmed
- Hydroxychloroquine-related hyperpigmentation. (2022) pubmed
- Taking hydroxychloroquine to heart. (2024) pubmed
- Hydroxychloroquine retinopathy - implications of research advances for rheumatology care. (2018) pubmed